Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertensionin vivo-Reference-Cited by-同舟云学术

Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertensionin vivo

Published:2014-03-03 Issue:4 Volume:59 Page:1492-1504
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fallowfield Jonathan A.¹,Hayden Annette L.²,Snowdon Victoria K.¹,Aucott Rebecca L.¹,Stutchfield Ben M.³,Mole Damian J.¹,Pellicoro Antonella¹,Gordon-Walker Timothy T.¹,Henke Alexander⁴,Schrader Joerg¹,Trivedi Palak J.⁵,Princivalle Marc⁶,Forbes Stuart J.³,Collins Jane E.²,Iredale John P.¹

Affiliation:

1. Medical Research Council/University of Edinburgh Centre for Inflammation Research; Queen's Medical Research Institute; Edinburgh UK

2. Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, School of Medicine; University of Southampton; UK

3. Scottish Centre for Regenerative Medicine; University of Edinburgh; UK

4. Medical Research Council/University of Edinburgh Centre for Reproductive Health; Queen's Medical Research Institute; Edinburgh UK

5. Centre for Liver Research/NIHR Biomedical Research Unit; 5th floor IBR Building, University of Birmingham; UK

6. Ferring Research Ltd.; Southampton UK

Funder

Wellcome Trust

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26627/fullpdf

Reference34 articles.

1. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension;Reynaert;Gut,2000

2. Quantitation of rat hepatic stellate cell contraction: stellate cells' contribution to sinusoidal resistance;Thimgan;Am J Physiol,1999

3. Stellate cells and the “reversible component” of portal hypertension;Franchis;Dig Liv Dis,2000

4. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators;Bhathal;J Hepatol,1985

5. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension;Rockey;Gastroenterology,1998

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology;Biochemical Pharmacology;2024-09

2. Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV–driven sinusoidal remodeling;JCI Insight;2024-05-07

3. Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue;Biochemical Pharmacology;2024-05

4. Delivering Relaxin Plasmid by Polymeric Metformin Lipid Nanoparticles for Liver Fibrosis Treatment;Current Drug Delivery;2024-03

5. Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension;Hepatobiliary & Pancreatic Diseases International;2024-02